Clinical trials
Recruiting Phase 4 trials in Poland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
40 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 11 |
| 2025 | 14 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 40 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 4 |
| Poznan University of Medical Sciences | 4 |
| Medical University of Silesia | 3 |
| Wroclaw Medical University | 3 |
| Hoffmann-La Roche | 2 |
| Medical University of Warsaw | 2 |
| National Institute of Cardiology, Warsaw, Poland | 2 |
| Novartis Pharmaceuticals | 2 |
| Silesian Centre for Heart Diseases | 2 |
| AOP Orphan Pharmaceuticals AG | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Atrial Fibrillation | 4 |
| Acute Coronary Syndrome | 3 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 |
| Myocardial Infarction | 3 |
| Cardiotoxicity | 2 |
| Coronary Artery Disease | 2 |
| Heart Failure | 2 |
| Hemorrhage | 2 |
| Lymphoma, Non-Hodgkin | 2 |
| Muscular Atrophy, Spinal | 2 |
Trials
Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.